27 results on '"Willis, Fenella"'
Search Results
2. Chemotherapy May Obviate Prophylactic Femoral Nail Surgery for Multiple Myeloma Patients With High Mirels’ Score Lesions and Impending Pathological Hip Fracture
3. The Development of a Diagnostic Tool to Help Primary Care Clinicians Manage Patients with Suspected Myeloma
4. P-175: Identifying risk factors of monoclonal gammopathy of undetermined significance (MGUS): a population-based study using data from the UK clinical practice research datalink (CPRD)
5. 3223 – THE DEVELOPMENT OF A DIAGNOSTIC TOOL TO HELP PRIMARY CARE CLINICIANS MANAGE PATIENTS WITH SUSPECTED MYELOMA
6. Case report: Interference from isatuximab on serum protein electrophoresis prevented demonstration of complete remission in a myeloma patient
7. OAB-003: CARDAMON:Carfilzomib (K) maintenance following Autologous Stem Cell Transplant (ASCT) or carfilzomib-cyclophosphamide-dexamethasone (KCd) consolidation for newly diagnosed (NDTE) multiple myeloma (MM)
8. First reported case of safe and efficacious use of tocilizumab for treatment of hyperinflammatory syndrome associated with COVID‐19 in an allogeneic stem cell transplant patient
9. Real‐world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study
10. Real Life Use of Imaging in the Management of Newly Diagnosed Patients with Myeloma- Practical Perspectives from a UK Hospital
11. Efficacy and Safety of Carfilzomib at 56mg/m2 with Cyclophosphamide and Dexamethasone (K56Cd) in Newly Diagnosed Multiple Myeloma Patients Followed By ASCT or K56Cd Consolidation: Initial Results of the Phase 2 Cardamon Study
12. Case study of patient receiving Clinical Hypnotherapy and Mindfulness (CHAM) Programme For A Severely Needle-Phobic Patient Requiring Bone Marrow Biopsy
13. Quality Improvement Project (QIP) - Integrated Therapies (IT) Service Development In A Busy London Teaching Hospital To Meet The Complex Biopsychosocial Needs Associated With Cancer Patients In Order To Improve The Patients’ Wellbeing And Quality Of Life (Qol)
14. RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature
15. Differences between chronic lymphocytic leukaemia and small lymphocytic lymphoma cells by proteomic profiling and SNP microarray analysis
16. Bruising and abnormal leucocytes on a blood film—a haematological emergency
17. Elevated Tricuspid Regurgitation Jet Velocity on Echocardiogram In Patients with Sickle Cell Disease Is Associated with Worse Steady State Functional Class, Poor Lung Function and Low Haemoglobin but Not Other Markers of Haemolysis or Endothelin-1.
18. Thrombopoietic agents
19. Prevalence Of Pulmonary Hypertension In Patients With Sickle Cell Disease
20. Infectious Causes of Chronic Immune Thrombocytopenia
21. Automated Erythrocytapheresis in Sickle Cell Disease: Impact On Hospital Admission Rate and Iron Loading.
22. Association of Mannose‐Binding Lectin Deficiency with Acute Invasive Aspergillosis in Immunocompromised Patients
23. Valproate synergizes with purine nucleoside analogues to induce apoptosis of B‐chronic lymphocytic leukaemia cells
24. Matrix Metalloproteinase 9 Levels Are Increased in Pegfilgrastim and Filgrastim Induced Mobilisation but Do Not Predict Efficiency of Mobilisation
25. Valproate, a Histone Deacetylase Inhibitor, Enhances Purine Nucleoside Analogues Induced Apoptosis of B-Chronic Lymphocytic Leukemia Cells.
26. Pegfilgrastim Alone Successfully Mobilizes Peripheral CD34+ Cells in Chemotherapy Naive Subjects with Solid Tumors: Initial Results of a Phase 1-2 Study.
27. Pegfilgrastim
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.